• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Pathog . Enhanced stability of M1 protein mediated by a phospho-resistant mutation promotes the replication of prevailing avian influenza viru

tetano

Editor, Senior Moderator
PLoS Pathog


. 2022 Jul 6;18(7):e1010645.
doi: 10.1371/journal.ppat.1010645. eCollection 2022 Jul.
Enhanced stability of M1 protein mediated by a phospho-resistant mutation promotes the replication of prevailing avian influenza virus in mammals


Chenxi Wang[SUP] 1 [/SUP], Runkang Qu[SUP] 1 [/SUP], Yanan Zong[SUP] 1 [/SUP], Chao Qin[SUP] 1 [/SUP], Litao Liu[SUP] 1 [/SUP], Xiaoyi Gao[SUP] 1 [/SUP], Honglei Sun[SUP] 1 [/SUP], Yipeng Sun[SUP] 1 [/SUP], Kin-Chow Chang[SUP] 2 [/SUP], Rui Zhang[SUP] 1 [/SUP], Jinhua Liu[SUP] 1 [/SUP], Juan Pu[SUP] 1 [/SUP]



Affiliations
Free PMC article

Abstract

Avian influenza virus (AIV) can evolve multiple strategies to combat host antiviral defenses and establish efficient infectivity in mammals, including humans. H9N2 AIV and its reassortants (such as H5N6 and H7N9 viruses) pose an increasing threat to human health; however, the mechanisms involved in their increased virulence remain poorly understood. We previously reported that the M1 mutation T37A has become predominant among chicken H9N2 isolates in China. Here, we report that, since 2010, this mutation has also been found in the majority of human isolates of H9N2 AIV and its emerging reassortants. The T37A mutation of M1 protein enhances the replication of H9N2 AIVs in mice and in human cells. Interestingly, having A37 instead of T37 increases the M1 protein stability and resistance to proteasomal degradation. Moreover, T37 of the H9N2 M1 protein is phosphorylated by protein kinase G (PKG), and this phosphorylation induces the rapid degradation of M1 and reduces viral replication. Similar effects are also observed in the novel H5N6 virus. Additionally, ubiquitination at K187 contributes to M1-37T degradation and decreased replication of the virus harboring T37 in the M1 protein. The prevailing AIVs thereby evolve a phospho-resistant mutation in the M1 protein to avoid viral protein degradation by host factors, which is advantageous in terms of replication in mammalian hosts.
 
Back
Top Bottom